AstraZeneca wins US approval for lymphoma drug


The Food and Drug Administration on Tuesday granted accelerated approval to AstraZeneca PLC for its Calquence for treating patients after chemotherapy or other treatments fail. The British drugmaker will have to do further testing confirm the drug's benefits and risks.



from Biotech News